Causeway Capital Management · portfolio as of Q2 2026, filed Aug 13, 2026
Latest 13F filing: Q2 2026 (filed Aug 13, 2026). No newer filing yet.
32 of 102 holdings are Undervalued or On Sale by our valuation (27% of the money).
On Sale: NWG, ZIM, SLM.
Valued by PaybackPrice; holdings from SEC 13F filings as of Jun 30, 2026. 20 not valued.
Sarah Ketterer's portfolio holds 122 stocks worth $9.2B at the end of Q2 2026. The largest positions are AZN, CCL, DB, SW and CP.
In Q2 2026, Sarah Ketterer opened 22 new positions (BSX, CM, CNQ, HTHT, IAG, EEM, JD, LRCX, MGA, NTES, OCANF, OTEX, ORLA, SLM, STN, SU, TD, VICI, ARCO, INTR, TRMD and GLBE) and added to ALK, ALL, DEO, META, FSM, IR, INDA, SMIN, EWT, KSA, JLL, PHG, LYV, MRK, NWG, NVO, PBR-A, PUK, SAP, SNN, INN, TAL, UNH, VEU, VWO, VIST, DB, AZN, CCL, BWLP and HAFN.
In Q2 2026, Sarah Ketterer sold out of EFXT, PDD, TME, QFIN, WHR, APTV and JBS and trimmed ADI, BUD, MT, BP, CP, CLS, C, CTSH, FIX, DIS, GSK, INFY, EFA, ACWI, JOYY, MSFT, RELX, SNY, SHG, TXN, VEA, VSS, WB, AU, G, PAGS, TIGO, INMD and ZIM.
CCL, ALK, CARR, BAP, AXS, EG, NVO, ZBH, NWG, GFI, AU, PFE, SNN, JD, GGB, PAGS, CGAU, G, ZIM, WB, ARCO, FINV, CIB, HDB, INFY, STN, OTEX, SHG, RNR, B, PDS and SLM are Undervalued or On Sale by our valuation.
Latest 13F filing: Q2 2026 (filed Aug 13, 2026). No newer filing yet.
From SEC Form 13F-HR — up to 45 days old at time of filing. Not a recommendation to buy or sell. Analyze any of these free →